You can now follow the latest news for free through the Telegram app
Click here to subscribe
لاهاي: On Friday, the European Union Medicines Agency confirmed that the Pfizer / Biontech vaccine is not related to the deaths recorded among people who have received it, and that it does not cause new side effects, based on the first data related to its launch.
The announcement by the Amsterdam-based agency came after reports reported that dozens, especially elderly people, died in Norway and other European countries after receiving the first dose of the vaccine.
The agency said that it had seen the deaths recorded, including those that were counted among a number of elderly people, and “concluded that the data do not show a relationship to the order to receive + Commernate + (Pfizer vaccine) and the cases do not raise any safety concerns.”
In the first safety update since the European Union launched the vaccination campaign in December, the agency reported that the data overall “is consistent with the known safety profile of the vaccine and no new side effects have been identified.”
She added that the reports of severe allergies sometimes did not go beyond what had been found so far on “this known side effect”.
She added, “The benefits of Kommernati + in preventing Covid-19 continue to outweigh any risks, and there are no recommended changes regarding the use of the vaccine.”
So far, the European Commission has approved two vaccines, Pfizer / Biontech and Moderna. It is expected to make its decision on the AstraZeneca vaccine later Friday.
Norway, in particular, recorded 33 deaths among 20,000 residents of nursing homes who had received the first dose of the Pfizer / Bionic vaccine.
The concern increased with the issuance of similar reports from several countries, including France, Denmark, Finland, Iceland and Sweden.
Oslo earlier this month did not indicate a direct link between deaths and the vaccine, but it did recommend that doctors take the overall health of the most vulnerable groups into account before immunization.
The European Medicines Agency said that “given the concerns emanating from Norway,” it was reviewing reports of people of any age dying after receiving the vaccine.
She added, “In many cases associated with people over the age of 65, the development of (several) diseases from which they suffer is the main rationale for death.”
She indicated that clinical tests of the Pfizer vaccine primarily included people from the age of 75 years and over. However, it urged the company to continue “to review in depth all reports regarding suspected side effects that may result in death.”